BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales Court of Protection Decisions |
||
You are here: BAILII >> Databases >> England and Wales Court of Protection Decisions >> Serious Medical Treatment, Guidance [2020] EWCOP 2 (17 January 2020) URL: http://www.bailii.org/ew/cases/EWCOP/2020/2.html Cite as: [2020] 1 WLR 641, [2020] EWCOP 2, [2020] WLR(D) 30, [2020] Med LR 55, [2020] COPLR 205, [2020] 3 All ER 873, [2020] WLR 641 |
[New search] [Printable PDF version] [View ICLR summary: [2020] WLR(D) 30] [Buy ICLR report: [2020] 1 WLR 641] [Help]
Applications to which this practice guidance applies
a. the decision-making capacity of; and
b. best interests of the person in question,
then, in principle, medical treatment may be provided to, withdrawn from or withheld in accordance with the agreement, without application to the court, in reliance upon the defence in section 5.[4]
Situations where consideration should be given to bringing an application to court
(a) finely balanced, or
(b) there is a difference of medical opinion, or
(c) a lack of agreement as to a proposed course of action from those with an interest in the person's welfare, or
(d) there is a potential conflict of interest on the part of those involved in the decision-making process
(not an exhaustive list)
Then it is highly probable that an application to the Court of Protection is appropriate. In such an event consideration must always be given as to whether an application to the Court of Protection is required.
a. where a medical procedure or treatment is for the primary purpose of sterilisation;
b. where a medical procedure is proposed to be performed on a person who lacks capacity to consent to it, where the procedure is for the purpose of a donation of an organ, bone marrow, stem cells, tissue or bodily fluid to another person;
c. a procedure for the covert insertion of a contraceptive device or other means of contraception;
d. where it is proposed that an experimental or innovative treatment to be carried out;
e. a case involving a significant ethical question in an untested or controversial area of medicine.
Pre-issue steps
a. to consider whether steps can be taken to resolve the relevant issues without the need for proceedings; but
b. to recognise that delay will invariably be inimical to P's welfare and where resolution cannot be achieved within P's own timescales proceedings should be issued.
Parties to proceedings
(Practice Direction B accompanying Part 9 sets out the persons who are to be notified that an application form has been issued.)
Allocation of the case
a. The seriousness of the consequences for P of the proposed treatment decision(s);
b. The seriousness of the interference with the ECHR rights of P involved the proposed treatment decision(s).
Matters to be considered at the first directions hearing
a. the expectation in applications for medical treatment is that P will normally be joined as a party;
b. When P is joined as a party to the application, the Official Solicitor will usually consent to act if invited to so by the court. There is no need for confirmation that there is no other person willing or able to act as litigation friend. The Official Solicitor will therefore normally be invited to act as litigation friend, and the standard practice is that the organisation which is, or will be, responsible for providing clinical or caring services to P will meet half of the costs incurred by the Official Solicitor (as P's solicitor). In urgent cases the issue of P's representation should be resolved as quickly as possible to ensure that those acting for P can quickly take the necessary steps to investigate the case and secure the best possible evidence in the available time scale.
Urgent hearings
a. proper arrangements should be made for family members to be able to participate in the hearing;
b. the Official Solicitor's office should be alerted so that (if possible) he is in a position to respond promptly. It is to be emphasised, as set out at paragraph 16 above, the Official Solicitor does not offer an 'out of hours' service. The Official Solicitor is prepared in principle to attend very urgent hearings as prospective litigation friend where the caring organisation agrees to pay half of his costs but ideally the Court should be asked to make an urgent order in respect of P's representation if time permits;
c. the Urgent Applications Judge and the Clerk of the Rules are to be alerted at the earliest opportunity that an application is likely;
d. a Word version of any draft order should be made available;
e. any statements in support of an application relating to life-sustaining treatment must set out the salient details of the relevant medical history which precedes the application and an assessment of any material which illuminates P's quality of life;
f. any IMCA or advocate report(s) relating to the treatment decision which are in existence should be filed;
g. Usually, and particularly if written evidence is limited or incomplete, one or more treating clinician should attend in person to provide evidence for the court. If such is not possible attendance may be permitted by telephone, or by video link, to provide evidence for the court.
a. The case should then be listed, avoiding delay, at the earliest opportunity to permit full consideration of the evidence and representations on behalf of P;
b. The represented applicant's advocate/legal representative should prepare a note of the hearing as soon as is reasonably practicable afterwards, and file a copy of the note with the court and serve a copy upon (a) the Official Solicitor or any other litigation friend appointed to act for P and (b) any respondent who was not present at the hearing.
Orders
Note 1 For purposes of section 37 Mental Capacity Act 2005 See the MCA 2005 (Independent Mental Capacity Advocates) (General) Regulations 2006, SI 2006/1832, regulation 4. [Back] Note 2 In the case of decisions concerning clinically assisted nutrition and hydration, treating clinicians are directed to the BMA/RCP Guidance (endorsed by the GMC): ‘Clinically assisted nutrition and hydration (CANH) and adults who lack the capacity to consent,’ available at www.bma.org.uk/canh. [Back] Note 3 Note, the Code of Practice must be read together with any subsequent case-law; the Code of Practice is also under review as at January 2020. [Back] Note 4 NHS Trust v Y [2018] UKSC 46 at paragraph 126. [Back] Note 5 Re P (Sexual Relations and Contraception) [2018] EWCOP 10 at paragraph 56, concerning the covert insertion of a contraceptive device. [Back] Note 6 ACCG v MN [2017] UKSC 22 at paragraph 38. [Back] Note 7 Rule 9.13 of the Court of Protection Rules 2017. [Back] Note 8 Rule 9.15 of the Court of Protection Rules 2017. [Back] Note 9 Rule 1.3(3)(e)(ii). [Back] Note 10 Practice Direction 3A, paragraph 2(a). Practice Direction 2A defines tiers of judge. [Back]